Citation: Junjun Huang, Ran Chen, Yajian Huang, Hang Zhang, Anran Zheng, Qing Xiao, Dan Wu, Ruxia Duan, Zhi Zhou, Fei He, Wei Yi. Discovery of an enantiopure N-[2-hydroxy-3-phenyl piperazine propyl]-aromatic carboxamide derivative as highly selective α_1D/1A-adrenoceptor antagonist and homology modelling[J]. Chinese Chemical Letters, ;2024, 35(11): 109594. doi: 10.1016/j.cclet.2024.109594 shu

Discovery of an enantiopure N-[2-hydroxy-3-phenyl piperazine propyl]-aromatic carboxamide derivative as highly selective α_1D/1A-adrenoceptor antagonist and homology modelling

Junjun Huang ^{a, 1, *,} ,
Ran Chen ^{a, 1} ,
Yajian Huang ^{b, 1} ,
Hang Zhang ^c ,
Anran Zheng ^a ,
Qing Xiao ^a ,
Dan Wu ^a ,
Ruxia Duan ^a ,
Zhi Zhou ^a ,
Fei He ^{c, *,} ,
Wei Yi ^{a, *,}

a.
The Fifth Affiliated Hospital, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China
b.
Department of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China
c.
School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China

huangjunjun1985@gzhmu.edu.cn

hefei8131@smu.edu.cn

yiwei@gzhmu.edu.cn

Received Date: 5 December 2023
Revised Date: 26 January 2024
Accepted Date: 29 January 2024
Available Online: 8 February 2024

Figures(5)

α₁-Adrenergic receptor (AR) blockers can be effective for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS), their usage is limited by cardiovascular-related side effects that are caused by the subtype nonselective nature or low selectivity of many current drugs. We previously reported that phenylpiperazine analogues with amide and propane linker were moderate α_1D/1A adrenoceptor antagonists and exhibited better anti-BPH effect than lead compound naftopidil (NAF) in vivo, however, with modest α_1D/1A-subtype selectivity. Herein, we replaced propane moiety with 2-hydroxypropanol linker and synthesized twenty-seven racemic derivatives with modified aromatic and hetero aromatic groups. Of these new compounds, quinoline surrogate 17 exhibited extremely weak antagonistic affinity on α_1B in both cell-based calcium assay and tissue-based functional assay, so that elicited significant α_1A/1B and α_1D/1B selectivity. Intriguingly, the R enantiomer of 17 preferentially displayed superior anti-BPH effect in rat model compared with S-17, supporting ligand regulates the receptor in a highly stereospecific manner. Finally, the computer-aided modelling research was also performed in order to deeply understand the unique binding mode of R-17 in complex with α_1A and the subtype receptor selectivity for R-17 was also rationalized in this study. Taken together, our work enriched the diversity of phenylpiperazines for the treatment of BPH/LUTS, and provided a basis for discovery of α_1D/1A-selective ligands.
- Benign prostatic hyperplasia,
- α₁-AR antagonist,
- Phenylpiperazine,
- Homology modelling,
- Subtype selectivity
1. [1]
  R.C. Langan, Urology 46 (2019) 223–232.
2. [2]
  S. Madersbacher, N. Sampson, Z. Culig, Gerontology 65 (2019) 458–464. doi: 10.1159/000496289
3. [3]
  B.M. Launer, K.T. McVary, W.A. Ricke, G.L. Lloyd, BJU Int. 127 (2021) 722–728. doi: 10.1111/bju.15286
4. [4]
  B. Chughtai, J.C. Forde, D.D.M. Thomas, et al., Nat. Rev. Dis. Primer 2 (2016) 16031. doi: 10.1038/nrdp.2016.31
5. [5]
  D.T. Price, D.A. Schwinn, J.W. Lomasney, et al., J. Urol. 150 (1993) 546–551. doi: 10.1016/s0022-5347(17)35544-1
6. [6]
  M. Yoshida, J. Kudoh, Y. Homma, et al., Clin. Interv. Aging 6 (2011) 161–172.
7. [7]
  J.R. Docherty, Eur. J. Pharmacol. 855 (2019) 305–320. doi: 10.1016/j.ejphar.2019.04.047
8. [8]
  G. Chiu, P.J. Connolly, S.A. Middleton, et al., Expert Opin. Ther. Pat. 18 (2008) 1351–1360. doi: 10.1517/13543770802571659
9. [9]
  D. Guo, J. Li, H. Lin, et al., J. Med. Chem. 59 (2016) 9489–9502. doi: 10.1021/acs.jmedchem.6b01217
10. [10]
  F. Zhao, J. Li, Y. Chen, et al., J. Med. Chem. 59 (2016) 3826–3839. doi: 10.1021/acs.jmedchem.5b02023
11. [11]
  M. Pallavicini, R. Budriesi, L. Fumagalli, et al., J. Med. Chem. 49 (2006) 7140–7149. doi: 10.1021/jm060358r
12. [12]
  R. Takei, I. Ikegaki, K. Shibata, et al., Jpn. J. Pharmacol. 79 (1999) 447–454. doi: 10.1254/jjp.79.447
13. [13]
  J.J. Huang, Y. Cai, Y.Z. Yi, et al., Eur. J. Pharmacol. 791 (2016) 473–481. doi: 10.1016/j.ejphar.2016.09.009
14. [14]
  J. Huang, F. He, M. Huang, Eur. J. Med. Chem. 96 (2015) 83–91. doi: 10.1016/j.ejmech.2015.04.005
15. [15]
  J.J. Huang, Z.H. Zhang, F. He, et al., Bioorg. Med. Chem. Lett. 28 (2018) 547–551. doi: 10.1016/j.bmcl.2018.01.068
16. [16]
  Q. Xiao, Q.M. Liu, R.C. Jiang, et al., Front. Pharmacol. 11 (2021) 594038. doi: 10.3389/fphar.2020.594038
17. [17]
  Q. Liu, Q. Xiao, X. Zhu, et al., Eur. J. Pharmacol. 870 (2020) 172817. doi: 10.1016/j.ejphar.2019.172817
18. [18]
  G.H. Kuo, C. Prouty, W.V. Murray, et al., J. Med. Chem. 43 (2000) 2183–2195. doi: 10.1021/jm9905918
19. [19]
  M. Deluigi, L. Morstein, M. Schuster, et al., Nat. Commun. 13 (2022) 382. doi: 10.1038/s41467-021-27911-3
20. [20]
  H. Fang, M.Y. Li, L. Xia, Chin. Chem. Lett. 18 (2007) 41–44.
21. [21]
  E.S. Stoddart, S. Senadheera, I.J.A. MacDougall, et al., PLoS One 6 (2011) e19695. doi: 10.1371/journal.pone.0019695
22. [22]
  L. Fumagalli, M. Pallavicini, R. Budriesi, et al., J. Med. Chem. 56 (2013) 6402–6412. doi: 10.1021/jm400867d
23. [23]
  X. Zhao, M. Yuan, B. Huang, et al., J. Mol. Graph. Model. 29 (2010) 126–136. doi: 10.1016/j.jmgm.2010.05.002
24. [24]
  A.J. Noble, R. Chess-Williams, C. Couldwell, et al., Br. J. Pharmacol. 120 (1997) 231–238. doi: 10.1038/sj.bjp.0700907
25. [25]
  C. Hosoda, A. Tanoue, M. Shibano, et al., Br. J. Pharmacol. 146 (2005) 456–466. doi: 10.1038/sj.bjp.0706325
26. [26]
  S.W. Seto, S. Bexis, P.A. McCormick, et al., Eur. J. Pharmacol. 644 (2010) 113–119. doi: 10.1016/j.ejphar.2010.06.035
27. [27]
  M.T. Quiles, M.A. Arbós, A. Fraga, et al., Prostate 70 (2010) 1044–1053. doi: 10.1002/pros.21138
28. [28]
  N.G. Bahey, E.A.E. El-Drieny, J. Microsc. Ultrastruct. 3 (2015) 75–81. doi: 10.1016/j.jmau.2015.01.002
29. [29]
  R. Barbaro, L. Betti, M. Botta, et al., J. Med. Chem. 44 (2001) 2118–2132. doi: 10.1021/jm010821u
1. [1]
  Shiqi Xu , Zi Ye , Shuang Shang , Fengge Wang , Huan Zhang , Lianguo Chen , Hao Lin , Chen Chen , Fang Hua , Chong-Jing Zhang . Pairs of thiol-substituted 1,2,4-triazole-based isomeric covalent inhibitors with tunable reactivity and selectivity. Chinese Chemical Letters, 2024, 35(7): 109034-. doi: 10.1016/j.cclet.2023.109034
2. [2]
  Feng-Fan Yang , Yin-Kang Ding , Lin-Kai Wu , Jiayue Tian , Shuai Dou , Wenjing Wang , Linfeng Liang . A 1,3,5-triazine μ₃-bridged neutral Cu(Ⅰ) framework with enhanced stability and CO₂ capture selectivity. Chinese Chemical Letters, 2025, 36(12): 110550-. doi: 10.1016/j.cclet.2024.110550
3. [3]
  Qijun Tang , Wenguang Tu , Yong Zhou , Zhigang Zou . High efficiency and selectivity catalyst for photocatalytic oxidative coupling of methane. Chinese Journal of Structural Chemistry, 2023, 42(12): 100170-100170. doi: 10.1016/j.cjsc.2023.100170
4. [4]
  Rui HUANG , Shengjie LIU , Qingyuan WU , Nanfeng ZHENG . Enhanced selectivity of catalytic hydrogenation of halogenated nitroaromatics by interfacial effects. Chinese Journal of Inorganic Chemistry, 2025, 41(1): 201-212. doi: 10.11862/CJIC.20240356
5. [5]
  Qiongqiong Wan , Zhourui Zhang , Mengmeng Zhao , Xianqin Ruan , Yanhong Hao , Jiajun Deng , Yunlang She , Minglei Yang , Yongxiang Song , Feng Jin , Ailin Wei , Sheng Zhong , Jie Zheng , Dong Xie , Suming Chen . Efficient diagnosis of benign and malignant pulmonary nodules based on Nano-zero-valent iron enhanced serum metabolic fingerprinting. Chinese Chemical Letters, 2025, 36(10): 110794-. doi: 10.1016/j.cclet.2024.110794
6. [6]
  Caixia Zhu , Qing Hong , Kaiyuan Wang , Yanfei Shen , Songqin Liu , Yuanjian Zhang . Single nanozyme-based colorimetric biosensor for dopamine with enhanced selectivity via reactivity of oxidation intermediates. Chinese Chemical Letters, 2024, 35(10): 109560-. doi: 10.1016/j.cclet.2024.109560
7. [7]
  Shaoming Dong , Yiming Niu , Yinghui Pu , Yongzhao Wang , Bingsen Zhang . Subsurface carbon modification of Ni-Ga for improved selectivity in acetylene hydrogenation reaction. Chinese Chemical Letters, 2024, 35(12): 109525-. doi: 10.1016/j.cclet.2024.109525
8. [8]
  Congyan Liu , Xueyao Zhou , Fei Ye , Bin Jiang , Bo Liu . Confined electric field in nano-sized channels of ionic porous framework towards unique adsorption selectivity. Chinese Chemical Letters, 2025, 36(2): 109969-. doi: 10.1016/j.cclet.2024.109969
9. [9]
  Sanmei Wang , Dengxin Yan , Wenhua Zhang , Liangbing Wang . Graphene-supported isolated platinum atoms and platinum dimers for CO₂ hydrogenation: Catalytic activity and selectivity variations. Chinese Chemical Letters, 2025, 36(4): 110611-. doi: 10.1016/j.cclet.2024.110611
10. [10]
  Qijun Tang , Wenguang Tu , Zhigang Zou . Solar-driven methane-to-ethanol conversion by “intramolecular junction” with both high activity and selectivity. Chinese Journal of Structural Chemistry, 2025, 44(6): 100597-100597. doi: 10.1016/j.cjsc.2025.100597
11. [11]
  Lijun Yan , Shiqi Chen , Penglu Wang , Xiangyu Liu , Lupeng Han , Tingting Yan , Yuejin Li , Dengsong Zhang . Hydrothermally stable metal oxide-zeolite composite catalysts for low-temperature NO_x reduction with improved N₂ selectivity. Chinese Chemical Letters, 2024, 35(6): 109132-. doi: 10.1016/j.cclet.2023.109132
12. [12]
  Hui Li , Yanxing Qi , Jia Chen , Juanjuan Wang , Min Yang , Hongdeng Qiu . Synthesis of amine-pillar[5]arene porous adsorbent for adsorption of CO₂ and selectivity over N₂ and CH₄. Chinese Chemical Letters, 2024, 35(11): 109659-. doi: 10.1016/j.cclet.2024.109659
13. [13]
  Shanyuan Bi , Jin Zhang , Dengchao Peng , Danhong Cheng , Jianping Zhang , Lupeng Han , Dengsong Zhang . Improved N₂ selectivity for low-temperature NO_x reduction over etched ZSM-5 supported MnCe oxide catalysts. Chinese Chemical Letters, 2025, 36(5): 110295-. doi: 10.1016/j.cclet.2024.110295
14. [14]
  Hua Liu , Jian Zhao , Qi Li , Xiang-Yu Zhang , Zhi-Wei Zheng , Kun Huang , Da-Bin Qin , Bin Zhao . Indium-captured zirconium-porphyrin frameworks displaying rare multi-selectivity for catalytic transfer hydrogenation of aldehydes and ketones. Chinese Chemical Letters, 2025, 36(6): 110593-. doi: 10.1016/j.cclet.2024.110593
15. [15]
  Xiujuan Wang , Yijie Wang , Luyun Cui , Wenqiang Gao , Xiao Li , Hong Liu , Weijia Zhou , Jingang Wang . Coordination-based synthesis of Fe single-atom anchored nitrogen-doped carbon nanofibrous membrane for CO₂ electroreduction with nearly 100% CO selectivity. Chinese Chemical Letters, 2024, 35(12): 110031-. doi: 10.1016/j.cclet.2024.110031
16. [16]
  Yajun Gao , Xinyu Yang , Jian Su , Zhizhong Li . A stable scandium(III) metal-organic framework with introduced nitrate ions for enhancing C₂H₆/C₂H₄ selectivity in the separation of MTO products. Chinese Journal of Structural Chemistry, 2025, 44(6): 100576-100576. doi: 10.1016/j.cjsc.2025.100576
17. [17]
  Wujun Jian , Mong-Feng Chiou , Yajun Li , Hongli Bao , Song Yang . Cu-catalyzed regioselective diborylation of 1,3-enynes for the efficient synthesis of 1,4-diborylated allenes. Chinese Chemical Letters, 2024, 35(5): 108980-. doi: 10.1016/j.cclet.2023.108980
18. [18]
  Chunhua Ma , Mengjiao Liu , Siyu Ouyang , Zhenwei Cui , Jingjing Bi , Yuqin Jiang , Zhiguo Zhang . Metal-free construction of diverse 1,2,4-triazolo[1,5-a]pyridines on water. Chinese Chemical Letters, 2025, 36(1): 109755-. doi: 10.1016/j.cclet.2024.109755
19. [19]
  Liangfeng Yang , Liang Zeng , Yanping Zhu , Qiuan Wang , Jinheng Li . Copper-catalyzed photoredox 1,4-amidocyanation of 1,3-enynes with N-amidopyridin-1-ium salts and TMSCN: Facile access to α-amido allenyl nitriles. Chinese Chemical Letters, 2024, 35(11): 109685-. doi: 10.1016/j.cclet.2024.109685
20. [20]
  . 第41卷第1期封面和目次. Acta Physico-Chimica Sinica, 2025, 41(1): -.

Get Citation

PDF

XML

Metrics

PDF Downloads(2)
Abstract views(1177)
HTML views(123)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Discovery of an enantiopure N-[2-hydroxy-3-phenyl piperazine propyl]-aromatic carboxamide derivative as highly selective α1D/1A-adrenoceptor antagonist and homology modelling

Metrics

通讯作者: 陈斌, bchen63@163.com

Discovery of an enantiopure N-[2-hydroxy-3-phenyl piperazine propyl]-aromatic carboxamide derivative as highly selective α_1D/1A-adrenoceptor antagonist and homology modelling